Post-dialysis fatigue and serum S100B protein in patients on chronic hemodialysis. A pilot study

被引:3
|
作者
Bossola, Maurizio [1 ,2 ]
Picca, Anna [2 ,3 ]
Marzetti, Emanuele [2 ,3 ]
Pepe, Gilda [2 ,4 ]
Antocicco, Manuela [3 ]
Di Stasio, Enrico [2 ,5 ]
机构
[1] Policlin Univ Fdn A Gemelli IRCCS, Serv Emodialisi, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Largo A Gemelli 8, I-00168 Rome, Italy
[3] Policlin Univ Fdn A Gemelli IRCCS, Dipartimento Geriatria Neurosci & Ortopedia, Rome, Italy
[4] Policlin Univ Fdn Policlin A Gemelli IRCCS, Div Chirurg Urgenza, Rome, Italy
[5] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Laboratorist & Infettivol, UOC Chim Biochim & Biol Mol Clin, Rome, Italy
关键词
blood-brain barrier; cytokines; fatigue; hemodialysis; S100B protein; MULTIPLE-SCLEROSIS; SICKNESS; MARKERS; INFLAMMATION; MECHANISMS; EXPRESSION; DEPRESSION; VARIABLES; SYMPTOMS; RECOVERY;
D O I
10.1111/1744-9987.13944
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Aim of the present study was to assess whether post-dialysis fatigue (PDF) may be related to pre- or post-dialysis levels of serum S100B protein. Hemodialysis patients (HD) who answered to be fatigued after their hemodialysis sessions when asked: "Do you feel worse after dialysis? if they answered yes" were considered to suffer from PDF. Serum Interleukins (IL-1 beta, IL-6, IL-10), TNF-alpha and S100B were assessed by ELISA kit. Results Thirty HD patients were studied: 22 (73.4%) reported to suffer from PDF. Serum S100B post-dialysis levels (median [IQR] = 17.4 mu g [7.1 to 30.9]) were significantly higher than serum S100B pre-dialysis levels (median [IQR] = 5 mu g [1.4 to 22.1]; p = 0.0001). S100B post-dialysis was significantly higher than S100B pre-dialysis either in patients with PDF or without PDF. Conclusions Pre- and post-dialysis values of serum S100B and its delta did not differ significantly between patients with and without PDF and were not associated with the length of the TIRD in patients on chronic hemodialysis.
引用
收藏
页码:471 / 479
页数:9
相关论文
共 50 条
  • [21] Plasma Soluble P-selectin, Interleukin-6 and S100B Protein in Patients with Schizophrenia: a Pilot Study
    Pinjari, Omar F.
    Dasgupta, Swapan K.
    Okusaga, Olaoluwa O.
    PSYCHIATRIC QUARTERLY, 2022, 93 (01) : 335 - 345
  • [22] Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders
    Levchuk, Lyudmila A.
    Roschina, Olga V.
    Mikhalitskaya, Ekaterina V.
    Epimakhova, Elena V.
    Simutkin, German G.
    Bokhan, Nikolay A.
    Ivanova, Svetlana A.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09):
  • [23] Jugular venous and arterial concentrations of serum S100B protein in patients with severe head injury
    Bouvier, Damien
    Eisenmann, Nathanael
    Gillart, Thierry
    Bonneau, Juliette
    Guelon, Dominique
    Schoeffler, Pierre
    Sapin, Vincent
    ANNALES DE BIOLOGIE CLINIQUE, 2012, 70 (03) : 269 - 275
  • [24] Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients
    Morera-Fumero, Armando L.
    Diaz-Mesa, Estefania
    Fernandez-Lopez, Lourdes
    Abreu-Gonzalez, Pedro
    Henry-Benitez, Manuel S.
    ACTA NEUROPSYCHIATRICA, 2023, 35 (03) : 138 - 146
  • [25] Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study
    Janigro, Damir
    Kawata, Keisuke
    Silverman, Erika
    Marchi, Nicola
    Diaz-Arrastia, Ramon
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [26] Chronic Oral Arsenic Exposure and Its Correlation with Serum S100B Concentration
    Golmohammadi, Jafar
    Jahanian-Najafabadi, Ali
    Aliomrani, Mehdi
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2019, 189 (01) : 172 - 179
  • [27] Chronic Oral Arsenic Exposure and Its Correlation with Serum S100B Concentration
    Jafar Golmohammadi
    Ali Jahanian-Najafabadi
    Mehdi Aliomrani
    Biological Trace Element Research, 2019, 189 : 172 - 179
  • [28] Serum levels of S100B and NSE proteins in Alzheimer's disease patients
    Chaves, Marcia L.
    Camozzato, Ana L.
    Ferreira, Eduardo D.
    Piazenski, Isabel
    Kochhann, Renata
    Dall'lgna, Oscar
    Mazzini, Guilherme S.
    Souza, Diogo O.
    Portela, Luis V.
    JOURNAL OF NEUROINFLAMMATION, 2010, 7
  • [29] Serum level of S100B in vitiligo patients: Is it a marker of disease activity?
    Badran, Aya Y.
    Gomaa, Ahmed Shawky
    El-Mahdy, Reham, I
    El Zohne, Randa Ahmed
    Kamal, Dalia Tarik
    Abou-Taleb, Doaa A. E.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, : e67 - e72
  • [30] S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis
    Camponeschi, Chiara
    De Carluccio, Maria
    Amadio, Susanna
    Clementi, Maria Elisabetta
    Sampaolese, Beatrice
    Volonte, Cinzia
    Tredicine, Maria
    Romano Spica, Vincenzo
    Di Liddo, Rosa
    Ria, Francesco
    Michetti, Fabrizio
    Di Sante, Gabriele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)